- Home
- MEDP vs QRVO Comparison
MEDP vs QRVO Comparison
Compare MEDP & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- QRVO
- Stock Information
- Founded
- MEDP 1992
- QRVO 1957
- Country
- MEDP United States
- QRVO United States
- Employees
- MEDP N/A
- QRVO N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- QRVO Semiconductors
- Sector
- MEDP Health Care
- QRVO Technology
- Exchange
- MEDP Nasdaq
- QRVO Nasdaq
- Market Cap
- MEDP 8.5B
- QRVO 7.1B
- IPO Year
- MEDP 2016
- QRVO 1997
- Fundamental
- Price
- MEDP $320.95
- QRVO $89.80
- Analyst Decision
- MEDP Hold
- QRVO Hold
- Analyst Count
- MEDP 11
- QRVO 19
- Target Price
- MEDP $338.90
- QRVO $89.56
- AVG Volume (30 Days)
- MEDP 408.6K
- QRVO 1.8M
- Earning Date
- MEDP 07-21-2025
- QRVO 07-29-2025
- Dividend Yield
- MEDP N/A
- QRVO N/A
- EPS Growth
- MEDP 33.36
- QRVO N/A
- EPS
- MEDP 13.09
- QRVO 0.58
- Revenue
- MEDP $2,156,580,000.00
- QRVO $3,718,971,000.00
- Revenue This Year
- MEDP $5.64
- QRVO $0.51
- Revenue Next Year
- MEDP $3.32
- QRVO $5.08
- P/E Ratio
- MEDP $24.64
- QRVO $155.03
- Revenue Growth
- MEDP 9.87
- QRVO N/A
- 52 Week Low
- MEDP $250.05
- QRVO $49.46
- 52 Week High
- MEDP $459.77
- QRVO $130.99
- Technical
- Relative Strength Index (RSI)
- MEDP 58.64
- QRVO 72.43
- Support Level
- MEDP $315.88
- QRVO $86.36
- Resistance Level
- MEDP $325.43
- QRVO $89.91
- Average True Range (ATR)
- MEDP 8.47
- QRVO 2.23
- MACD
- MEDP 1.18
- QRVO 0.38
- Stochastic Oscillator
- MEDP 75.78
- QRVO 94.82
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.